耳鼻喉科設備市場 - 全球和區域分析:按產品類型、最終用戶、按地區 - 分析和預測(2024-2033)
市場調查報告書
商品編碼
1522697

耳鼻喉科設備市場 - 全球和區域分析:按產品類型、最終用戶、按地區 - 分析和預測(2024-2033)

ENT Devices Market - A Global and Regional Analysis: Focus on Product Type, End User, and Region - Analysis and Forecast, 2024-2033

出版日期: | 出版商: BIS Research | 英文 124 Pages | 商品交期: 1-5個工作天內

價格

2023年全球耳鼻喉科設備市場規模為170.2億美元。

預計到 2033 年,市場規模將達到 308.2 億美元,2024-2033 年預測期間複合年成長率為 6.03%。耳鼻喉科設備市場包括各種用於診斷、治療和管理耳鼻喉疾病的醫療工具。由於耳鼻喉疾病的盛行率不斷上升以及對微創手術的需求,該市場正在迅速成長。助聽器、人工電子耳和內視鏡等技術的進步正在改善患者的治療效果並擴大耳鼻喉科醫生的能力。

該市場為醫療保健提供者和醫療設備製造商提供了巨大的成長機會,推動了持續的創新和發展。耳鼻喉科設備市場的成長是由多種因素推動的,例如耳鼻喉科疾病負擔的增加、研究出版物數量的增加以及耳鼻喉科設備的臨床試驗導致對耳鼻喉科設備的需求不斷增加。此外,微創耳鼻喉手術的日益普及和需求正在導致更有效和創新產品的開發。此外,政府措施和老年人口的增加也在推動市場成長方面發揮重要作用。此外,這些產品透過各種分銷管道(例如線上平台和零售店)提供,進一步促進了市場擴張和接觸全球消費者。

主要市場統計數據
預測期 2024-2033
2024年評估 181.9億美元
2033 年預測 308.2億美元
複合年成長率 6.03%

耳鼻喉科設備市場包括用於診斷、治療和管理耳鼻喉疾病的各種醫療設備。正如世界衛生組織 (WHO) 在 2024 年 2 月發布的情況說明書中指出的那樣,隨著聽力損失負擔的增加,約 10 億年輕人因不安全的聆聽習慣而遭受永久性或永久性聽力損失。預計到2050 年將出現一定程度的聽力損失,並面臨可避免的聽力損失的風險。根據世界聾人聯合會統計,全球約有7,000萬殘障人士,其中80%以上居住在開發中國家中國家。這導致對用於診斷和手術應用的各種耳鼻喉科設備的需求迅速增加。

由於耳鼻喉科疾病的盛行率不斷上升以及對微創手術的需求,該市場正在迅速擴大。助聽器、人工電子耳和內視鏡等設備的技術進步正在改善患者的治療效果並擴大耳鼻喉科醫師的工作領域。這種成長為醫療保健提供者和醫療設備製造商創造了新的機會,導致耳鼻喉科設備市場持續擴大。

政府的批准、報銷政策和 OTC 助聽器的可用性促進了其在臨床實踐中的採用,並為其納入標準耳鼻喉科護理鋪平了道路。隨著人們對聽力損失早期檢測和非侵入性診斷方法的認知不斷增強,未來耳鼻喉科助聽器市場預計將進一步擴大和多元化。

該報告研究了全球耳鼻喉科設備市場,並提供了市場概述,包括按產品類型、最終用戶、地區和參與市場的公司概況分類的趨勢。

目錄

執行摘要

第1章 市場

  • 產業展望
  • COVID-19對耳鼻喉科設備市場的影響
  • 市場動態

第2章 全球耳鼻喉科市場(依最終使用者)

  • 醫院及門診中心
  • 耳鼻喉科門診
  • 其他

第3章 全球耳鼻喉科市場(依產品類型)

  • 診斷設備
  • 手術設備
  • 助聽器
  • 視覺化裝置
  • 消耗品
  • 其他

第4章 區域

  • 區域概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 其他地區

第5章市場-競爭基準化分析與公司概況

  • 競爭格局
  • 公司簡介
    • Ambu A/S
    • Boston Scientific Corporation
    • Cochlear Limited
    • Demant A/S
    • BEBIG Medical GmbH
    • Hoya Corporation
    • Johnson & Johnson
    • KARL STORZ SE & Co, KG
    • Medtronic plc
    • Olympus Corporation
    • Richard Wolf GmbH
    • Smith and Nephew plc
    • Sonova Holding AG
    • Stryker Corporation

第6章調查方法

Product Code: BHM1146SB

Global ENT Devices Market Industry Overview

The global ENT devices market was valued at $17.02 billion in 2023 and is expected to reach $30.82 billion by 2033, growing at a CAGR of 6.03% during the forecast period 2024-2033. The ENT devices market includes various medical tools used to diagnose, treat, and manage ear, nose, and throat conditions. This market is rapidly growing due to the increasing prevalence of ENT disorders and the demand for minimally invasive procedures. Advances in technology, including hearing aids, cochlear implants, and endoscopes, are improving patient outcomes and expanding the capabilities of ENT specialists. The market presents significant growth opportunities for healthcare providers and medical device manufacturers, driving ongoing innovation and development. The growth of the ENT devices market has been driven by several factors, such as the rising burden of ENT disorders, growing research publications, and clinical trials in ENT devices, which have led to increased demand for ENT devices. Additionally, growing adoption and demand for minimally invasive ENT procedures have led to the development of more effective and innovative products. Furthermore, initiatives by governments and the growing geriatric population have also played a significant role in driving market growth. Moreover, the expanding availability of these products through various distribution channels, including online platforms and retail stores, has further facilitated market expansion and accessibility to consumers worldwide.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2024 - 2033
2024 Evaluation$18.19 Billion
2033 Forecast$30.82 Billion
CAGR6.03%

The ENT devices market includes a variety of medical tools used to diagnose, treat, and manage ear, nose, and throat conditions. With the increasing burden of hearing loss, as mentioned by the World Health Organisation in their factsheet in February 2024, approximately 1,000 million young adults are at risk of permanent and avoidable hearing loss owing to unsafe listening practices, and approximately 2,500 million people are expected to have some degree of hearing loss by 2050. In addition, according to the World Federation of the Deaf, approximately 70 million people are deaf globally, and more than 80% of them are in developing countries. This has led to a surge in demand for a diverse range of ENT devices for diagnostic and surgical purposes.

With the rising prevalence of ENT disorders and the demand for minimally invasive procedures, the market has been rapidly growing. Technological advancements in devices such as hearing aids, cochlear implants, and endoscopes are improving patient outcomes and broadening the scope of ENT specialists. This growth presents new opportunities for healthcare providers and medical device manufacturers, positioning the ENT devices market for ongoing expansion.

Facilitation of its adoption in clinical practices by government approvals, reimbursement policies, and availability of OTC hearing aids has paved the way for their integration into standard ENT care. As awareness about early hearing disorder detection and its non-invasive diagnostic method continues to rise, the ENT devices market is poised for further expansion and diversification in the coming years.

Industrial Impact

The growth of the ENT devices market has not only provided relief to individuals having ENT disorders but has also had a notable industrial impact. Manufacturers and suppliers of these products have witnessed increased demand, leading to expanded production capacities and job creation within the industry.

Market Segmentation:

Segmentation 1: by Product Type

  • Diagnostic Devices
  • Surgical Devices
  • Hearing Aids
  • Visualization Devices
  • Consumables
  • Others

Hearing Aids Segment to Dominate the ENT Devices Market (by Product Type)

The hearing aids segment is poised to dominate the ENT devices market based on product type. This dominance can be attributed to the increasing prevalence of hearing disorders such as hearing loss globally.

Segmentation 2: by End User (Surgical Devices)

  • Hospitals
  • Ambulatory Centers
  • ENT Specialty Clinics

Hospitals Segment to Dominate the ENT Surgical Devices Market (by End User)

The hospitals segment is anticipated to dominate the ENT surgical devices market based on end users. This dominance stems from a high volume of complex surgeries being performed there. Hospital's advanced medical infrastructure, specialized units, and skilled professionals make them the top choice for intricate ENT procedures. Additionally, the hospital's access to a wide range of ENT surgical devices and technologies boosts surgery precision and outcomes.

Segmentation 3: by End User (Diagnostic Devices)

  • Hospitals
  • Ambulatory Centers
  • ENT Speciality Clinics
  • Others

Hospitals Segment to Dominate the ENT Diagnostic Devices Market (by End User)

The hospitals segment is expected to dominate the ENT diagnostic devices market based on end users. Hospitals have the necessary infrastructure, resources, and specialized medical staff to effectively use advanced ENT diagnostic devices. They also handle a high volume of complex ENT cases and serve as primary referral centers, driving the demand for these devices in hospital settings.

Segmentation 4: by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Rest-of-Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest-of-Asia-Pacific
  • Rest-of-the-World
    • Latin America
    • Middle East and Africa

The North America region is positioned to hold a significant share of the global market for several compelling reasons. The Asia-Pacific region encompasses a large and diverse population, including a significant proportion of ENT disorders-affected individuals, thereby creating a substantial market demand for ENT surgical and diagnostic devices products. The market in this region is mainly driven by technological advancements in healthcare and an increasing preference for minimally invasive ENT procedures. Along with this rising burden of hearing loss, the growing geriatric population, leading to increasing demand for ENT devices, is leading to the growing adoption of ENT devices such as cochlear implants, hearing aids, visualization devices, diagnostic devices, surgical devices, consumables, and others.

Recent Developments in the ENT Devices Market

  • In May 2024, Olympus Corporation announced the availability of the new DVM-B2 Digital Video Monitor, an all-in-one video processor and monitor for use with single-use endoscopes for both bronchoscopy and ENT, including the H-SteriScope Single-use Flexible Bronchoscopes and the E-SteriScope Single-use Flexible Rhinolaryngoscopes. The DVM-B2 Digital Video Monitor, manufactured by Hunan Vathin Medical Instruments Co., Ltd., was distributed exclusively by Olympus America, Inc.
  • In March 2024, Cochlear Limited finalized the acquisition of the Oticon Medical cochlear implant division from Demant A/S. The deal, which did not involve a headline purchase price, effectively ended Demant's participation in the hearing implants sector.
  • In March 2024, Olympus Corporation announced an expansion of its ENT product line to facilitate common otolaryngologic procedures in outpatient settings. It launched the CELERIS single-use sinus debrider system, the Celon Elite, and the single-use Celon ProBreath for treating hypertrophy of nasal turbinates. The introduction of CELERIS and Celon Elite aimed to help physicians transition non-urgent rhinology procedures, such as recurring polypectomies and functional endoscopic sinus surgery, from the OR to their offices.
  • In January 2024, RCA Accessories announced the upcoming launch of three new upgraded premium hearing aids with advanced functionality, extended battery life, and volume controls. Additionally, the company introduced a best-in-class protection plan for its customers. Each of the premium models, launched under the RCA brand, catered to specific users and their needs and were priced significantly lower than competitive products.

Demand - Drivers, Challenges, and Opportunities

Market Demand Drivers:

Upsurge in Prevalence of Hearing Disorders: Hearing disorders are a growing global concern. According to the WHO, about 1 billion young adults risk permanent hearing loss due to unsafe listening, and by 2050, 2.5 billion people will have some hearing loss. The World Federation of the Deaf reports 70 million deaf individuals worldwide, with over 80% in developing countries.

Market Challenges:

High Cost of ENT Procedure: The high cost of ENT procedures limits the ENT devices market. Advanced treatments such as cochlear implants, minimally invasive surgeries, and modern hearing aids are expensive and often unaffordable for many patients, especially where healthcare coverage is limited. This can lead to delayed or avoided treatments, impacting patient health. Additionally, financial constraints on hospitals and providers restrict investment in new ENT technologies, hindering market growth.

Market Opportunities:

Increasing Demand for Cosmetic ENT Procedures: The increasing demand for cosmetic ENT procedures presents a significant market opportunity for ENT devices. As more people seek aesthetic and functional improvements, procedures such as rhinoplasty and otoplasty are becoming more popular. This trend has led to a greater need for specialized ENT devices that offer precision, safety, and improved outcomes in cosmetic surgeries, spurring innovation and growth in the ENT devices market.

How can this report add value to an organization?

Product/Innovation Strategy: The global ENT devices market has been segmented based on product type and end user.

Growth/Marketing Strategy: New offerings accounted for the maximum number of key developments in the ENT devices market between January 2021 and July 2024.

Competitive Strategy: The global ENT devices market is a highly fragmented market, with many smaller and private companies constantly entering the market. Key players in the ENT devices market analyzed and profiled in the study involve established players that offer various kinds of products and services.

Methodology

Key Considerations and Assumptions in Market Engineering and Validation

  • The base year considered for the calculation of the market size is 2023. A historical year analysis has been done for the period FY2019-FY2022. The market size has been estimated for FY2023 and projected for the period FY2024-FY2033.
  • The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of ENT devices.
  • The market contribution of ENT devices anticipated to be launched in the future has been calculated based on the historical analysis of the solutions.
  • Revenues of the companies have been referenced from their annual reports for FY2023.
  • The market has been mapped based on the available ENT device offerings. All the key companies with significant offerings in this field have been considered and profiled in this report.

Primary Research:

The primary sources involve industry experts in ENT devices, including the market players offering products. Resources such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.

The key data points taken from the primary sources include:

  • validation and triangulation of all the numbers and graphs
  • validation of the report's segmentation and key qualitative findings
  • understanding the competitive landscape and business model
  • current and proposed production values of a product by market players
  • validation of the numbers of the different segments of the market in focus
  • percentage split of individual markets for regional analysis

Secondary Research

Open Sources

  • Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
  • Annual reports, SEC filings, and investor presentations of the leading market players
  • Company websites and detailed study of their product portfolio
  • Gold standard magazines, journals, white papers, press releases, and news articles
  • Paid databases

The key data points taken from the secondary sources include:

  • segmentations and percentage shares
  • data for market value
  • key industry trends of the top players of the market
  • qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
  • quantitative data for mathematical and statistical calculations

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.

Based on product type, the ENT devices hearing aids segment players leading the market captured around 62.95% of the market's presence as of 2023. Diagnostic devices, surgical devices, visualization devices, consumables, and others, on the other hand, accounted for approximately 3.25%, 16.95%, 9.38%, 2.29%, and 4.92% of the market presence in 2023, respectively.

Some prominent names established in this market are:

  • Ambu A/S
  • Boston Scientific Corporation
  • Cochlear Limited
  • Demant A/S
  • BEBIG Medical GmbH
  • Hoya Corporation
  • Johnson & Johnson
  • KARL STORZ SE & Co, KG
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Smith and Nephew plc
  • Sonova Holding AG
  • Stryker Corporation

Table of Contents

Executive Summary

Scope and Definition

Inclusion and Exclusion Criteria

1 Markets

  • 1.1 Industry Outlook
    • 1.1.1 Trends: Current and Future Impact Assessment
      • 1.1.1.1 Miniaturization of Sensors and Components in Hearing Aids and Implants
      • 1.1.1.2 Increasing Product Approval by Regulatory Authorities Leading to Various New Offerings in the Market
    • 1.1.2 Patent Analysis
      • 1.1.2.1 Patent Filing Trend (by Country)
      • 1.1.2.2 Patent Filing Trend (by Year)
    • 1.1.3 Regulatory Landscape
    • 1.1.4 Supply Chain Analysis
    • 1.1.5 Ongoing Clinical Trial Studies
  • 1.2 Impact of COVID-19 on ENT Devices Market
  • 1.3 Market Dynamics
    • 1.3.1 Market Drivers
      • 1.3.1.1 Upsurge in Prevalence of Hearing Disorders
      • 1.3.1.2 Growing Geriatric Population Leading to Increased Demand for ENT Devices
      • 1.3.1.3 Growing Preference for Minimally Invasive Procedures in ENT Specialty
    • 1.3.2 Market Restraints
      • 1.3.2.1 High Cost of ENT Procedure
      • 1.3.2.2 Social Stigma Associated with Hearing Disorder
    • 1.3.3 Market Opportunities
      • 1.3.3.1 Increasing Demand for Cosmetic ENT Procedures

2 Global ENT Devices Market, by End User

  • 2.1 Hospitals and Ambulatory Centers
  • 2.2 ENT Clinics
  • 2.3 Others

3 Global ENT Devices Market, by Product Type

  • 3.1 Diagnostic Devices
  • 3.2 Surgical Devices
  • 3.3 Hearing Aids
  • 3.4 Visualization Devices
  • 3.5 Consumables
  • 3.6 Others

4 Region

  • 4.1 Regional Summary
  • 4.2 North America
    • 4.2.1 Regional Overview
    • 4.2.2 Factors Driving the Market Growth
    • 4.2.3 Factors Impeding/Limiting the Market Growth
    • 4.2.4 By Product Type
    • 4.2.5 By End User
    • 4.2.6 U.S.
      • 4.2.6.1 By Product Type
      • 4.2.6.2 By End User
    • 4.2.7 Canada
      • 4.2.7.1 By Product Type
      • 4.2.7.2 By End User
  • 4.3 Europe
    • 4.3.1 Regional Overview
    • 4.3.2 Factors Driving the Market Growth
    • 4.3.3 Factors Impeding/Limiting the Market Growth
    • 4.3.4 By Product Type
    • 4.3.5 By End User
    • 4.3.6 Germany
      • 4.3.6.1 By Product Type
      • 4.3.6.2 By End User
    • 4.3.7 U.K.
      • 4.3.7.1 By Product Type
      • 4.3.7.2 By End User
    • 4.3.8 France
      • 4.3.8.1 By Product Type
      • 4.3.8.2 By End User
    • 4.3.9 Italy
      • 4.3.9.1 By Product Type
      • 4.3.9.2 By End User
    • 4.3.10 Rest-of-Europe
      • 4.3.10.1 By Product Type
      • 4.3.10.2 By End User
  • 4.4 Asia-Pacific
    • 4.4.1 Regional Overview
    • 4.4.2 Factors Driving the Market Growth
    • 4.4.3 Factors Impeding/Limiting the Market Growth
    • 4.4.4 By Product Type
    • 4.4.5 By End User
    • 4.4.6 China
      • 4.4.6.1 By Product Type
      • 4.4.6.2 By End User
    • 4.4.7 Japan
      • 4.4.7.1 By Product Type
      • 4.4.7.2 By End User
    • 4.4.8 India
      • 4.4.8.1 By Product Type
      • 4.4.8.2 By End User
    • 4.4.9 Australia
      • 4.4.9.1 By Product Type
      • 4.4.9.2 By End User
    • 4.4.10 Rest-of-Asia-Pacific
      • 4.4.10.1 By Product Type
      • 4.4.10.2 By End User
  • 4.5 Rest-of-the-World
    • 4.5.1 Regional Overview
    • 4.5.2 Factors Driving the Market Growth
    • 4.5.3 Factors Impeding/Limiting the Market Growth
    • 4.5.4 By Product Type
    • 4.5.5 By End User
    • 4.5.6 Latin America
      • 4.5.6.1 By Product Type
      • 4.5.6.2 By End User
    • 4.5.1 Middle East and Africa
      • 4.5.1.1 By Product Type
      • 4.5.1.2 By End User

5 Markets - Competitive Benchmarking & Company Profiles

  • 5.1 Competitive Landscape
    • 5.1.1 Key Strategies and Development
    • 5.1.2 Partnerships, Alliances, and Business Expansions
    • 5.1.3 New Offerings
    • 5.1.4 Mergers and Acquisitions
    • 5.1.5 Regulatory and Legal Activities
  • 5.2 Company Profiles
    • 5.2.1 Ambu A/S
      • 5.2.1.1 Overview
      • 5.2.1.2 Top Products
      • 5.2.1.3 Top Competitors
      • 5.2.1.4 Target Customers/End Users
      • 5.2.1.5 Analyst View
    • 5.2.2 Boston Scientific Corporation
      • 5.2.2.1 Overview
      • 5.2.2.2 Top Products
      • 5.2.2.3 Top Competitors
      • 5.2.2.4 Target Customers/End Users
      • 5.2.2.5 Analyst View
    • 5.2.3 Cochlear Limited
      • 5.2.3.1 Overview
      • 5.2.3.2 Top Products/Product Portfolio
      • 5.2.3.3 Top Competitors
      • 5.2.3.4 Target Customers/End Users
      • 5.2.3.5 Analyst View
    • 5.2.4 Demant A/S
      • 5.2.4.1 Overview
      • 5.2.4.2 Top Products/Product Portfolio
      • 5.2.4.3 Top Competitors
      • 5.2.4.4 Target Customers/End Users
      • 5.2.4.5 Analyst View
    • 5.2.5 BEBIG Medical GmbH
      • 5.2.5.1 Overview
      • 5.2.5.2 Top Products
      • 5.2.5.3 Target Customers/End Users
      • 5.2.5.4 Analyst View
    • 5.2.6 Hoya Corporation
      • 5.2.6.1 Overview
      • 5.2.6.2 Top Products/Product Portfolio
      • 5.2.6.3 Top Competitors
      • 5.2.6.4 Target Customers/End Users
      • 5.2.6.5 Analyst View
    • 5.2.7 Johnson & Johnson
      • 5.2.7.1 Overview
      • 5.2.7.2 Top Products/Product Portfolio
      • 5.2.7.3 Top Competitors
      • 5.2.7.4 Target Customers/End Users
      • 5.2.7.5 Analyst View
    • 5.2.8 KARL STORZ SE & Co, KG
      • 5.2.8.1 Overview
      • 5.2.8.2 Top Products/Product Portfolio
      • 5.2.8.3 Top Competitors
      • 5.2.8.4 Target Customers/End Users
      • 5.2.8.5 Analyst View
    • 5.2.9 Medtronic plc
      • 5.2.9.1 Overview
      • 5.2.9.2 Top Products/Product Portfolio
      • 5.2.9.3 Top Competitors
      • 5.2.9.4 Target Customers/End Users
      • 5.2.9.5 Analyst View
    • 5.2.10 Olympus Corporation
      • 5.2.10.1 Overview
      • 5.2.10.2 Top Products/Product Portfolio
      • 5.2.10.3 Top Competitors
      • 5.2.10.4 Target Customers/End Users
      • 5.2.10.5 Analyst View
    • 5.2.11 Richard Wolf GmbH
      • 5.2.11.1 Overview
      • 5.2.11.2 Top Products/Product Portfolio
      • 5.2.11.3 Top Competitors
      • 5.2.11.4 Target Customers/End Users
      • 5.2.11.5 Analyst View
    • 5.2.12 Smith and Nephew plc
      • 5.2.12.1 Overview
      • 5.2.12.2 Top Products/Product Portfolio
      • 5.2.12.3 Top Competitors
      • 5.2.12.4 Target Customers/End Users
      • 5.2.12.5 Analyst View
    • 5.2.13 Sonova Holding AG
      • 5.2.13.1 Overview
      • 5.2.13.2 Top Products/Product Portfolio
      • 5.2.13.3 Top Competitors
      • 5.2.13.4 Target Customers/End Users
      • 5.2.13.5 Analyst View
    • 5.2.14 Stryker Corporation
      • 5.2.14.1 Overview
      • 5.2.14.2 Top Products/Product Portfolio
      • 5.2.14.3 Top Competitors
      • 5.2.14.4 Target Customers/End Users
      • 5.2.14.5 Analyst View

6 Research Methodology

  • 6.1 Data Sources
    • 6.1.1 Primary Data Sources
    • 6.1.2 Secondary Data Sources
    • 6.1.3 Data Triangulation
  • 6.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Global ENT Devices Market (by Region), $Million, 2023, 2027, and 2033
  • Figure 2: Global ENT Devices Market (by Product), $Million, 2023 and 2033
  • Figure 3: Key Events to Keep Track of in the ENT Devices Market
  • Figure 4: Number of ENT Devices Patents (by Country), January 2020-June 2024
  • Figure 5: Number of ENT Devices Patents (by Year), January 2020-June 2024
  • Figure 6: Impact Analysis of Market Navigating Factors, 2023-2033
  • Figure 7: Global Population Aged 85 years and Above, Million, 2010-2022
  • Figure 8: U.S. ENT Devices Market, $Million, 2023-2033
  • Figure 9: Canada ENT Devices Market, $Million, 2023-2033
  • Figure 10: Germany ENT Devices Market, $Million, 2023-2033
  • Figure 11: U.K. ENT Devices Market, $Million, 2023-2033
  • Figure 12: France ENT Devices Market, $Million, 2023-2033
  • Figure 13: Italy ENT Devices Market, $Million, 2023-2033
  • Figure 14: Rest-of-Europe ENT Devices Market, $Million, 2023-2033
  • Figure 15: China ENT Devices Market, $Million, 2023-2033
  • Figure 16: Japan ENT Devices Market, $Million, 2023-2033
  • Figure 17: India ENT Devices Market, $Million, 2023-2033
  • Figure 18: Australia ENT Devices Market, $Million, 2023-2033
  • Figure 19: Rest-of-Asia-Pacific ENT Devices Market, $Million, 2023-2033
  • Figure 20: Latin America ENT Devices Market, $Million, 2023-2033
  • Figure 21: Middle East and Africa ENT Devices Market, $Million, 2023-2033
  • Figure 22: Share of Strategic Initiatives, 2021-2024
  • Figure 23: Strategic Initiatives (by Year), January 2021- July 2024
  • Figure 24: Partnerships, Alliances, and Business Expansions, January 2021-July 2024
  • Figure 25: New Offerings, January 2021-July 2024
  • Figure 26: Mergers and Acquisitions, January 2021-July 2024
  • Figure 27: Regulatory and Legal, January 2021-July 2024
  • Figure 28: Data Triangulation
  • Figure 29: Top-Down and Bottom-Up Approach
  • Figure 30: Assumptions and Limitations

List of Tables

  • Table 1: Global ENT Devices Market Snapshot
  • Table 2: Opportunities across Regions
  • Table 3: Global ENT Devices Market, Inclusion Criteria
  • Table 4: Global ENT Devices Market, Exclusion Criteria
  • Table 5: Key Trends, Global ENT Devices Market
  • Table 6: Global ENT Devices Market, Regulatory Approvals and New Offerings
  • Table 7: North America ENT Devices Market Regulatory Framework
  • Table 8: Europe ENT Devices Market Regulatory Framework
  • Table 9: Asia-Pacific ENT Devices Market Regulatory Framework
  • Table 10: Rest-of-the-World ENT Devices Market Regulatory Framework
  • Table 11: Recent Ongoing Clinical Trials in Global ENT Devices Market
  • Table 12: Global Prevalence of Hearing Loss, 2019-2021
  • Table 13: Prices of ENT Procedures
  • Table 14: Global ENT Surgical Devices Market (by End User), $Million, 2023-2033
  • Table 15: Global ENT Diagnostic Devices Market (by End User), $Million, 2023-2033
  • Table 16: Global ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 17: Global ENT Devices Market (by Region), $Million, 2023-2033
  • Table 18: North America ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 19: North America ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
  • Table 20: North America ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
  • Table 21: U.S. ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 22: U.S. ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
  • Table 23: U.S. ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
  • Table 24: Canada ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 25: Canada ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
  • Table 26: Canada ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
  • Table 27: Europe ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 28: Europe ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
  • Table 29: Europe ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
  • Table 30: Germany ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 31: Germany ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
  • Table 32: Germany ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
  • Table 33: U.K. ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 34: U.K. ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
  • Table 35: U.K. ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
  • Table 36: France ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 37: France ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
  • Table 38: France ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
  • Table 39: Italy ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 40: Italy ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
  • Table 41: Italy ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
  • Table 42: Rest-of-Europe ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 43: Rest-of-Europe ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
  • Table 44: Rest-of-Europe ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
  • Table 45: Asia-Pacific ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 46: Asia-Pacific ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
  • Table 47: Asia-Pacific ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
  • Table 48: China ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 49: China ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
  • Table 50: China ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
  • Table 51: Japan ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 52: Japan Germany ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
  • Table 53: Japan Germany ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
  • Table 54: India ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 55: India ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
  • Table 56: India ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
  • Table 57: Australia ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 58: Australia ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
  • Table 59: Australia ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
  • Table 60: Rest-of-Asia-Pacific ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 61: Rest-of-Asia-Pacific ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
  • Table 62: Rest-of-Asia-Pacific ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
  • Table 63: Rest-of-the-World ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 64: Rest-of-the-World ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
  • Table 65: Rest-of-the-World ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
  • Table 66: Latin America ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 67: Latin America ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
  • Table 68: Latin America ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033
  • Table 69: Middle East and Africa ENT Devices Market (by Product Type), $Million, 2023-2033
  • Table 70: Middle East and Africa ENT Devices Market, Diagnostic Devices (by End User), $Million, 2023-2033
  • Table 71: Middle East and Africa ENT Devices Market, Surgical Devices (by End User), $Million, 2023-2033